Study proves hepatitis C drugs reduce liver-related deaths by nearly half

A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.<br />
<br />
 <br />
<br />
The finding builds on a December 2 …
Ingeniería
Enlace: Study proves hepatitis C drugs reduce liver-related deaths by nearly half